These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35131083)

  • 1. STK11 Loss: A Novel Mechanism for Melanoma Metastasis with Therapeutic Implications.
    Azin M; Demehri S
    J Invest Dermatol; 2022 Apr; 142(4):1007-1009. PubMed ID: 35131083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous Melanoma.
    Dzung A; Saltari A; Tiso N; Lyck R; Dummer R; Levesque MP
    J Invest Dermatol; 2022 Apr; 142(4):1171-1182.e10. PubMed ID: 34757069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
    Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
    Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.
    Huang FJ; Steeg PS; Price JE; Chiu WT; Chou PC; Xie K; Sawaya R; Huang S
    Cancer Res; 2008 Dec; 68(23):9634-42. PubMed ID: 19047140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
    Wu ZS; Cheng XW; Wang XN; Song NJ
    Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines.
    Vultur A; Villanueva J; Krepler C; Rajan G; Chen Q; Xiao M; Li L; Gimotty PA; Wilson M; Hayden J; Keeney F; Nathanson KL; Herlyn M
    Oncogene; 2014 Apr; 33(14):1850-61. PubMed ID: 23624919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of STAT3 targets a subpopulation of invasive melanoma stem-like cells.
    Kulesza DW; Przanowski P; Kaminska B
    Cell Biol Int; 2019 Jun; 43(6):613-622. PubMed ID: 30958597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma.
    Colón-Bolea P; García-Gómez R; Casar B
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor.
    Wang X; Qu H; Dong Y; Wang G; Zhen Y; Zhang L
    Cancer Biomark; 2018; 23(1):67-77. PubMed ID: 30010109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression.
    Yang W; Khoury E; Guo Q; Prabhu SA; Emond A; Huang F; Gonçalves C; Zhan Y; Plourde D; Nichol JN; Dahabieh MS; Miller WH; Del Rincón SV
    Oncogene; 2020 Apr; 39(18):3650-3665. PubMed ID: 32132651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudopodium enriched atypical kinase 1(PEAK1) promotes invasion and of melanoma cells by activating JAK/STAT3 signals.
    Pan M; Yin X; Huang YC
    Bioengineered; 2021 Dec; 12(1):5045-5055. PubMed ID: 34365903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.
    Liu J; Qu X; Shao L; Hu Y; Yu X; Lan P; Guo Q; Han Q; Zhang J; Zhang C
    Cancer Biol Ther; 2018 Mar; 19(3):160-168. PubMed ID: 29370558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.
    Delyon J; Chevret S; Jouary T; Dalac S; Dalle S; Guillot B; Arnault JP; Avril MF; Bedane C; Bens G; Pham-Ledard A; Mansard S; Grange F; Machet L; Meyer N; Legoupil D; Saiag P; Idir Z; Renault V; Deleuze JF; Hindie E; Battistella M; Dumaz N; Mourah S; Lebbe C;
    J Invest Dermatol; 2018 Jan; 138(1):58-67. PubMed ID: 28843487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-135b is a novel oncogenic factor in cutaneous melanoma by targeting LATS2.
    Hu Y; Wang Q; Zhu XH
    Melanoma Res; 2019 Apr; 29(2):119-125. PubMed ID: 30480622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway.
    Berköz M; Özkan-Yılmaz F; Özlüer-Hunt A; Krośniak M; Türkmen Ö; Korkmaz D; Keskin S
    Pharmacol Rep; 2021 Apr; 73(2):650-663. PubMed ID: 33609273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional
    Pore N; Wu S; Standifer N; Jure-Kunkel M; de Los Reyes M; Shrestha Y; Halpin R; Rothstein R; Mulgrew K; Blackmore S; Martin P; Meekin J; Griffin M; Bisha I; Proia TA; Miragaia RJ; Herbst R; Gupta A; Abdullah SE; Raja R; Frigault MM; Barrett JC; Dennis PA; Ascierto ML; Oberst MD
    Cancer Discov; 2021 Nov; 11(11):2828-2845. PubMed ID: 34230008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.
    Hüser L; Sachindra S; Granados K; Federico A; Larribère L; Novak D; Umansky V; Altevogt P; Utikal J
    Int J Cancer; 2018 Dec; 143(12):3131-3142. PubMed ID: 29905375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.
    Villares GJ; Zigler M; Bar-Eli M
    Oncotarget; 2011; 2(1-2):8-17. PubMed ID: 21378407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
    Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.